Search Results - Revathi Ananthakrishnan
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Systematic comparison of the statistical operating characteristics of various Phase I oncology designs by Revathi Ananthakrishnan, Stephanie Green, Mark Chang, Gheorghe Doros, Joseph Massaro, Michael LaValley
Published in Contemporary Clinical Trials Communications (2017-03-01)Get full text
Article -
4
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study by Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Published in Blood Advances (2017-06-01)Get full text
Article
